Archive - April 2022
Protecting pharma’s most valuable asset
‘Longest Reported Infection’: How Long Did This Man Have COVID-19?
COVID-19: When Will Pfizer’s Antiviral Pill Be Ready For Use? Here’s What To Know
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for Caplyta (lumateperone) for Specific Patient Populations
Third COVID-19 Vaccine Dose Protection Only Good For 3 Months?
COVID-19 Becomes Third Leading Cause Of Death In US: CDC
Does COVID-19 Increase Shingles Risk In People Over 50?
Best Mattresses for Joint Pain and How to Sleep With SI Joint Pain